- Stocks
- Healthcare
- NYSE: MDT

Price (delayed)

$126.70

Market cap

$170.8B

P/E Ratio

59.21

Dividend/share

$2.32

EPS

$2.14

Enterprise value

$196.05B

The price to earnings (P/E) is 81% higher than the 5-year quarterly average of 32.8 and 60% higher than the last 4 quarters average of 36.9

The net income has contracted by 46% YoY and by 18% from the previous quarter

What are the main financial stats of MDT

Market
Valuations
Earnings

Shares outstanding

1.35B

Market cap

$170.8B

Enterprise value

$196.05B

Price to earnings (P/E)

59.21

Price to book (P/B)

3.36

Price to sales (P/S)

6.11

EV/EBIT

56.51

EV/EBITDA

31.83

EV/Sales

7.02

Revenue

$27.93B

EBIT

$3.47B

EBITDA

$6.16B

Free cash flow

$4.63B

Per share
Balance sheet
Liquidity

EPS

$2.14

Free cash flow per share

$3.44

Book value per share

$37.71

Revenue per share

$20.74

TBVPS

$27.4

Total assets

$97.27B

Total liabilities

$46.34B

Debt

$30.32B

Equity

$50.76B

Working capital

$13.81B

Debt to equity

0.6

Current ratio

2.1

Quick ratio

1.58

Net debt/EBITDA

4.1

Margins
Efficiency
Dividend

EBITDA margin

22.1%

Gross margin

63.9%

Net margin

10.4%

Operating margin

11.4%

Return on assets

3.1%

Return on equity

5.7%

Return on invested capital

7.6%

Return on capital employed

4.1%

Return on sales

12.4%

Dividend yield

1.83%

DPS

$2.32

Payout ratio

108.4%

How has the Medtronic stock price performed over time

Intraday

-0.47%

1 week

-3.22%

1 month

5.03%

1 year

28.06%

YTD

8.16%

QTD

7.25%

How have Medtronic's revenue and profit performed over time

Revenue

$27.93B

Gross profit

$17.83B

Operating income

$3.2B

Net income

$2.89B

Gross margin

63.9%

Net margin

10.4%

The operating income has shrunk by 50% YoY and by 10% QoQ

The net income has contracted by 46% YoY and by 18% from the previous quarter

The operating margin has declined by 45% year-on-year and by 11% since the previous quarter

MDT's net margin is down by 39% year-on-year and by 18% since the previous quarter

What is Medtronic's growth rate over time

What is Medtronic stock price valuation

P/E

59.21

P/B

3.36

P/S

6.11

EV/EBIT

56.51

EV/EBITDA

31.83

EV/Sales

7.02

The price to earnings (P/E) is 81% higher than the 5-year quarterly average of 32.8 and 60% higher than the last 4 quarters average of 36.9

The EPS has declined by 46% year-on-year and by 19% since the previous quarter

The stock's price to book (P/B) is 34% more than its 5-year quarterly average of 2.5 and 24% more than its last 4 quarters average of 2.7

The company's equity fell by 2% YoY

MDT's P/S is 45% higher than its 5-year quarterly average of 4.2 and 25% higher than its last 4 quarters average of 4.9

Medtronic's revenue has decreased by 10% YoY

How efficient is Medtronic business performance

The company's return on invested capital has shrunk by 50% YoY and by 12% QoQ

MDT's return on assets is down by 47% year-on-year and by 18% since the previous quarter

Medtronic's return on equity has decreased by 46% YoY and by 19% QoQ

The return on sales has declined by 43% year-on-year and by 10% since the previous quarter

What is MDT's dividend history

DPS

$2.32

Dividend yield

1.83%

Payout ratio

108.4%

Recent dividends

How did Medtronic financials performed over time

The total assets is 110% greater than the total liabilities

The company's current ratio fell by 24% YoY and by 2.8% QoQ

Medtronic's quick ratio has decreased by 23% YoY and by 3.1% from the previous quarter

MDT's debt is 40% smaller than its equity

Medtronic's debt to equity has increased by 22% YoY

MDT's debt is up by 19% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.